The Effect of Hyperuricemia and Allopurinol Treatment Outcome of Greft in Kidney Transplant Recipients

Saime Paydas, Ersin Nazlıcan, İlker Unal

Volume 6 · Issue 3 · pp. 483–487

Published: 2023-12-31

Abstract

Introduction: Kidney transplant recipients(KTRs) may have high level of serum uric acid(SUA) due to greft dysfunction and immunosuppressives. In this study, we evaluated effect of high SUA levels and allopurinol therapy in KTRs on renal functions. Patients and Methods: 113 of 233 KTRs had elevated SUA level(G1). Fiftyseven of G1 received allopurinol treatment(G1A+) and 56 patients G1A-) did not. 56 of 118 patients who were followed for five years(G5) were hyperuricemic(G5-1) and 26 of G5-1 treated with allopurinol(G5-1A+) and 30 of them did not(G5-1A-). 62 patients were normourisemic(G5-2). GFR

Full text

The full text of this article is available through the PDF link.

Copyright & License

This article retains the copyright and licence terms stated at its original publication. The journal's later licensing policy does not replace or amend those terms.

Read the original article PDF for the applicable copyright and reuse terms.

Journal copyright and licensing policy

Cite this article

Citation BibTeXRIS / EndNote
APA

Vancouver

Scroll to Top